Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma

Anti-CD20-containing chemotherapy regimens have become the standard of care for patients with follicular lymphoma needing cytotoxic therapy. Four randomized trials demonstrated a clinical benefit for patients treated with rituximab. However, no long-term follow up (i.e. > 5 years) of these trials...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Bachy, Emmanuel, Houot, Roch, Morschhauser, Franck, Sonet, Anne, Brice, Pauline, Belhadj, Karim, Cartron, Guillaume, Audhuy, Bruno, Fermé, Christophe, Feugier, Pierre, Sebban, Catherine, Delwail, Vincent, Maisonneuve, Hervé, Le Gouill, Steven, Lefort, Sophie, Brousse, Nicole, Foussard, Charles, Salles, Gilles
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2013
Assuntos:
Original Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3696615/
https://ncbi.nlm.nih.gov/pubmed/23645690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.082412
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados